https://www.ibtomato.com/ExternalView.aspx?type=1&no=20099IB토마토ko2026-11-11T10:41:53+09:00KCC, 투자자산 2.8조 줄었다…매각이익 환원 '불투명'https://www.ibtomato.com/ExternalView.aspx?type=1&no=20102IB토마토ko2026-11-11T11:01:55+09:00포스코인터, LNG 투자에 이익도 뛴다…그룹 '2인자' 입지 강화https://www.ibtomato.com/ExternalView.aspx?type=1&no=20115IB토마토ko2026-11-11T18:43:36+09:00IBK투자증권, 예심 7건 모두 통과…스팩 넘어 일반 IPO로https://www.ibtomato.com/ExternalView.aspx?type=1&no=20118IB토마토ko2026-11-11T18:17:13+09:00H&S하이텍, ACF 이익 27% 뛰었지만…전자 적자에 빛바랜 성장https://www.ibtomato.com/ExternalView.aspx?type=1&no=20101IB토마토ko2026-11-11T09:38:30+09:00리센스메디컬, 공모가 반토막…만기 코앞 LB인베 회수 '비상'https://www.ibtomato.com/ExternalView.aspx?type=1&no=20105IB토마토ko2026-11-11T18:02:02+09:00(한화의 국방칩 도전)①한화시스템, 자체 팹 검토…채울 물량 있나https://www.ibtomato.com/ExternalView.aspx?type=1&no=20098IB토마토ko2026-11-11T09:21:05+09:00동아제약, 박카스 품고 현금 불린다…'FCF 절반 환원' 지킬까https://www.ibtomato.com/ExternalView.aspx?type=1&no=20124IB토마토ko2026-11-12T20:05:00+09:00(합정역 7번출구)미국 선거에 출렁인 엔화…지금 환전할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=20130IB토마토ko2026-11-12T18:34:59+09:00(공시톺아보기)밸류업 공시, 대주주는 절세·소액주주는 배당https://www.ibtomato.com/ExternalView.aspx?type=1&no=20127IB토마토ko2026-11-12T18:07:31+09:00(유증레이다)엔젠바이오, 증자금은 빚 갚고…태양광 인수에 또 20억https://www.ibtomato.com/ExternalView.aspx?type=1&no=20125IB토마토ko2026-11-12T16:48:46+09:00CJ제일제당, 사료 덜고 북미에 무게…차입 감축은 숙제https://www.ibtomato.com/ExternalView.aspx?type=1&no=20122IB토마토ko2026-11-12T15:48:22+09:00(크레딧시그널)롯데쇼핑, 백화점 이익 59% 증가…차입금도 반등https://www.ibtomato.com/ExternalView.aspx?type=1&no=20119IB토마토ko2026-11-12T08:00:00+09:00(단독)정선그룹, 또 쪼갰다…'북서울산업'·'쌍용레미콘 영종' 신설https://www.ibtomato.com/ExternalView.aspx?type=1&no=20090IB토마토ko2026-11-10T17:11:00+09:00토비스, 미국 물량 떠난 중국공장…적자 늘고 부채비율 두 배https://www.ibtomato.com/ExternalView.aspx?type=1&no=20095IB토마토ko2026-11-10T16:48:06+09:00PS일렉트로닉스, 서버로 매출 늘어도…재고에 마르는 현금https://www.ibtomato.com/ExternalView.aspx?type=1&no=20086IB토마토ko2026-11-10T16:25:00+09:00씨엔티테크, 'AC 1호 상장' 도전…사업모델 시장서 통할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=20093IB토마토ko2026-11-10T16:17:46+09:00인뱅 3사 신용평가…토스뱅크만 한 단계 낮은 이유https://www.ibtomato.com/ExternalView.aspx?type=1&no=20089IB토마토ko2026-11-10T16:11:40+09:00(퇴직연금 500조)③기금 키워 아낀 비용, 가입자에게 돌아갈까https://www.ibtomato.com/ExternalView.aspx?type=1&no=20083IB토마토ko2026-11-10T14:28:21+09:00덕양에너젠, 정유사 수소 공급 기회…수천억 투자금이 관건https://www.ibtomato.com/ExternalView.aspx?type=1&no=20081IB토마토ko2026-11-09T17:12:52+09:00서진시스템, 팔수록 마르는 현금…CB로 대출 돌려막기https://www.ibtomato.com/ExternalView.aspx?type=1&no=20087IB토마토ko2026-11-10T14:21:45+09:00딜리셔스, 이사 줄어도 보수한도 15억…계속 적용 추진https://www.ibtomato.com/ExternalView.aspx?type=1&no=20111IB토마토ko2026-11-11T17:33:50+09:00금호석화, 안전·환경 다지고 고부가 확대…실적 반등 노린다https://www.ibtomato.com/ExternalView.aspx?type=1&no=20113IB토마토ko2026-11-11T17:22:38+09:00대한항공, 고객만족 1위·매출 첫 5조…통합 앞두고 날았다https://www.ibtomato.com/ExternalView.aspx?type=1&no=20109IB토마토ko2026-11-11T16:35:03+09:00(크레딧시그널)갤럭시아머니트리, 이익 늘어도 현금은 '빠듯'https://www.ibtomato.com/ExternalView.aspx?type=1&no=20107IB토마토ko2026-11-11T14:50:17+09:00(IPO클립)엠비디, 공모가 27% 낮추고 투자 축소…확약도 '0'https://www.ibtomato.com/ExternalView.aspx?type=1&no=20106IB토마토ko2026-11-11T10:56:24+09:00(IPO인사이트)마더스제약, 비교기업이 높인 몸값…공모가 적정할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=20103IB토마토ko2026-11-11T10:30:26+09:00(데스크칼럼)오늘 막은 반대매매, 석 달 뒤는https://www.ibtomato.com/ExternalView.aspx?type=1&no=20067IB토마토ko2026-11-09T06:00:00+09:00(오너의 해외동맹)①상미당, 트럼프 인맥 접촉…파트너는 관세 소송https://www.ibtomato.com/ExternalView.aspx?type=1&no=20071IB토마토ko2026-11-09T06:00:00+09:00(게임 AI셈법)②게임으로 벌어 AI에 투자…홀로서기는 아직https://www.ibtomato.com/ExternalView.aspx?type=1&no=20068IB토마토ko2026-11-09T06:00:00+09:00(좀비SPAC)③합병 못 한 스팩 쌓이는데…증권사는 왜 또 만드나https://www.ibtomato.com/ExternalView.aspx?type=1&no=20079IB토마토ko2026-11-09T17:03:25+09:00하나은행, 대손비용 39% 급증…지주 건전성도 '흔들'https://www.ibtomato.com/ExternalView.aspx?type=1&no=20070IB토마토ko2026-11-09T06:00:00+09:00스틱·JKL, 신흥에스이씨 회수 난항…전환가 낮춰도 주가는 반값https://www.ibtomato.com/ExternalView.aspx?type=1&no=20074IB토마토ko2026-11-09T16:06:52+09:00SK증권, 휴림 관련사 유증 잇단 차질…15억 예정 보수 '안갯속'